Why denying addiction treatment in jails, prisons is inhumane
Evidence shows medications to treat substance-use disorder treatment in jails and prisons are lifesaving, yet they’re too often denied. Learn more with the AMA.
April 9, 2021: State Advocacy Update
Kentucky and Virginia enact opioid litigation abatement laws and more in the latest State Advocacy Update.
AMA applauds Biden Administration’s first-year drug policy priorities
The agenda outlined today by the Biden Administration tackles overdoses and substance use disorder head-on in ways that will reduce stigma and remove barriers to treatment.
Meet the AMA’s Capitol Hill allies protecting patients and practices
Learn how a diverse group of lawmakers has worked with the AMA to carry favorable legislation over the finish line and block harmful measures.
COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
Feb. 26, 2021: State Advocacy Update
South Dakota physician assistant independent practice bill defeated and more in the latest State Advocacy Update.
Feb. 5, 2021: National Advocacy Update
Expanding patients’ access to buprenorphine and more in the latest National Advocacy Update.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights